PAMCX
Price
$90.91
Change
-$0.03 (-0.03%)
Updated
Sep 18 closing price
Net Assets
20.82B
TFGRX
Price
$46.45
Change
+$0.15 (+0.32%)
Updated
Sep 18 closing price
Net Assets
2.28B
Interact to see
Advertisement

PAMCX vs TFGRX

PAMCX vs TFGRX Comparison Chart in %
View a ticker or compare two or three
VS
PAMCX vs. TFGRX commentary
Sep 21, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PAMCX is a Hold and TFGRX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PAMCX has more cash in the bank: 20.8B vs. TFGRX (2.28B). PAMCX (0.00) and TFGRX (0.00) have matching dividends . PAMCX was incepted earlier than TFGRX: PAMCX (26 years) vs TFGRX (7 years). PAMCX (1.02) is less costly to investors than TFGRX (0.86). TFGRX is a more actively managed with annual turnover of: 85.00 vs. PAMCX (31.50). PAMCX has a lower initial minimum investment than TFGRX: PAMCX (2500) vs TFGRX (50000). TFGRX annual gain was more profitable for investors over the last year : -2.09 vs. PAMCX (-6.24). TFGRX return over 5 years is better than : 0.35 vs. PAMCX (-26.21).
PAMCXTFGRXPAMCX / TFGRX
Total Expense Ratio1.020.79129%
Annual Report Gross Expense Ratio1.020.86119%
Fund Existence26 years7 years-
Gain YTD-0.12111.739-1%
Front LoadN/AN/A-
Min. Initial Investment2500500005%
Min. Initial Investment IRAN/AN/A-
Net Assets20.8B2.28B911%
Annual Yield % from dividends0.000.00-
Returns for 1 year-6.24-2.09299%
Returns for 3 years-2.0240.80-5%
Returns for 5 years-26.210.35-7,583%
Returns for 10 years22.29N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GGOUX21.680.02
+0.09%
Goldman Sachs Mid Cap Growth R6
FGDDX43.380.04
+0.09%
Fidelity Advisor® Dividend Growth A
JOHIX29.66-0.01
-0.03%
JOHCM International Select Institutional
SIPIX30.42-0.13
-0.43%
SEI Mid-Cap I (SIMT)
BRSUX16.86-0.08
-0.47%
MFS Blended Research Small Cap Eq R4